Initial United States experience with the Paracor HeartNet**Paracor Medical, Inc, Sunnyvale, Calif. myocardial constraint device for heart failure

Journal of Thoracic and Cardiovascular Surgery

Volumn 133, Issue 1, 2007, Pages 204-209

  Klodell Jr , Charles T ^a   McGiffin, David C ^b   Rayburn, Barry K ^b   Sun, Benjamin ^c   Abraham, William T ^c   Conte, John V ^d   Russell, Stuart D ^d   Pae Jr , Walter E ^e   Boehmer, John P ^e   Aranda Jr , Juan M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ALDOSTERONE RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANEMIA; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEFIBRILLATOR; DIABETES MELLITUS; DISEASE DURATION; ELECTRONICS; FEASIBILITY STUDY; FEMALE; FOOD AND DRUG ADMINISTRATION; HEART ASSIST DEVICE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; IMPLANTATION; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG DISEASE; MALE; MOBILIZATION; OPERATION DURATION; PARACOR HEARTNET DEVICE; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL RISK; UNITED STATES;

ADULT; AGED; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; POSTOPERATIVE COMPLICATIONS;

EID: 33845788204     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.08.070     Document Type: Article

References (16)

1. Packer M. The impossible task of developing a new treatment for heart failure. J Card Fail 8 (2002) 193-196
2. Slaughter M.S. Destination therapy: the future is arriving. Congest Heart Fail 11 (2005) 155-156
3. Chen F.Y., and Cohn L.H. The surgical treatment of heart failure. A new frontier: nontransplant surgical alternatives in heart failure. Cardiol Rev 10 (2002) 326-333
4. Loebe M., Soltero E., Thohan V., Lafuente J.A., and Noon G.P. New surgical therapies for heart failure. Curr Opin Cardiol 18 (2003) 194-198
5. Acker M.A. Surgical therapies for heart failure. J Card Fail 10 6 Suppl (2004) S220-S224
6. Auricchio A., Stellbrink C., Block M., Sack S., Vogt J., Bakker P., et al., The Guidant Congestive Heart Failure Research Group. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. Circulation 99 (1999) 2993-3001
7. Abraham W.T., and Hayes D.L. Cardiac resynchronization therapy for heart failure. Circulation 108 (2003) 2596-2603
8. Abraham W.T., Young J.B., Leon A.R., Adler S., Bank A.J., Hall S.A., et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 110 (2004) 2864-2868
9. Aranda Jr. J.M., Woo G.W., Conti J.B., Schofield R.S., Conti C.R., and Hill J.A. Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration. Am J Cardiol 95 (2005) 889-891
10. Aranda Jr. J.M., Woo G.W., Schofield R.S., Handberg E.M., Hill J.A., Curtis A.B., et al. Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment with optimal device function. J Am Coll Cardiol 46 (2005) 2193-2198
11. Walsh R.G. Design and features of the Acorn CorCap Cardiac Support Device: the concept of passive mechanical diastolic support. Heart Fail Rev 10 (2005) 101-107
12. Blom A.S., Mukherjee R., Pilla J.J., Lowry A.S., Yarbrough W.M., Mingoia J.T., et al. Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction. Circulation 112 (2005) 1274-1283
13. Blom A.S., Pilla J.J., Gorman III R.C., Gorman J.H., Mukherjee R., Spinale F.G., et al. Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep. Heart Fail Rev 10 (2005) 125-139
14. Cheng A., Nguyen T.C., Malinowski M., Langer F., Liang D., Daughters G.T., et al. Passive ventricular constraint prevents transmural shear strain progression in left ventricle remodeling. Circulation 114 1 Suppl (2006) I79-I86
15. Power J.M., Raman J., Byrne M.J., and Alferness C.A. Efficacy of the Acorn Cardiac Support Device in animals with heart failure secondary to high rate pacing. Heart Fail Rev 10 (2005) 117-123
16. Acker M.A. Clinical results with the Acorn cardiac restraint device with and without mitral valve surgery. Semin Thorac Cardiovasc Surg 17 (2005) 361-363